Day 1: Wednesday, June 18, 2008
Research Workshop:
• Welcome and Introductions • Timothy L. Brenner, PharmD
• Integrating Research Into Your Clinical Practice • Barry
R. Goldspiel, PharmD, BCOP, FISOPP
• Research Models Within Various Practice Sites (click on individual links
below)
– Private Practice Medical Office • Siu-Fun Wong, PharmD,
FASHP, FCSHP
– Institutional Pharmacy Practice Research • Christopher
A. Fausel, PharmD, BCPS, BCOP
– Patient Safety Research • Roxanne Dobish, RPh
– Investigational Drug Services • Scott A. Soefje, PharmD,
BCOP
– Academic/Comprehensive Cancer Center • Jill M. Kolesar,
PharmD, BCPS, FCCP
• Getting Started in Practical Pharmacy Research • Paul
R. Hutson, PharmD, BCOP
• Lunch/“Meet The Experts” Session • Faculty
• Ethics and Research • Jillian Davis & Mark T. Holdsworth,
PharmD, BCOP
• Research Projects: The Real Do’s and Don’ts • Christopher A. Fausel,
PharmD, BCPS, BCOP, Jill M. Kolesar, PharmD, BCPS, FCCP, & Siu-Fun Wong, PharmD, FASHP, FCSHP
Symposium:
The Molecular Basis of Cancer: Fundamental and Evolving Concepts
Supported by Genentech BioOncology (non CE program)
• The Molecular Basis of Cancer • Mark M. Moasser, MD
General Session:
Keynote Address/John G. Kuhn Lecture
Safe Medication Practices • Michael R. Cohen, RPh, MS,
ScD, FASHP – President, Institute for Safe Medication Practices
Symposium:
Optimizing Patient Adherence to Self-Administered Chemotherapy:
Best Practices for Hematology/Oncology Pharmacists
(Supported by an educational grant from Pfizer)
• Patient Adherence Overview • Gary C. Yee, PharmD, FCCP, BCOP
• Patient Adherence Program • Shauna S. Choi, PharmD
• Oral Chemotherapy Adherence: Best Practices, Next Steps • Joseph S. Bubalo,
PharmD, BCOP, BCPS
Day 2: Thursday, June 19, 2008
Symposium:
Emerging Strategies for the Treatment of Metastatic Melanoma:
The Role of Monoclonal Antibodies in Targeted Immunotherapy
(Supported by an educational grant from Medarex, Inc. & Bristol-Myers
Squibb Company)
• Current Management of Metastatic Melanoma • Van Anh Trinh,
PharmD, BCOP
• Targeting Metastatic Melanoma • Jamie C. Poust, PharmD, BCOP
Symposium:
A New Era of Treatment Options for Chronic Idiopathic
Thrombocytopenic Purpura
(Supported by an educational grant from Amgen)
• Epidemiology, Pathophysiology, and Initial Management of Chronic
ITP • Jane M. Pruemer, PharmD, BCOP, FASHP
• New Options After First-Line Therapy for Chronic ITP • Julianna A. Burzynski,
PharmD, BCPS, BCOP
BCOP Presentation:
Novel Treatment Strategies in Myelodysplastic Syndromes
• R. Donald Harvey, PharmD, BCPS, BCOP
Clinical Session:
Updates in Cancer Prevention: What’s New • Judith
A. Smith, PharmD, FCCP, BCOP
Technical Session:
Understanding the Challenges Faced By Patients in Need
• Jeanne L. Anderson, CPhT
BCOP Presentation:
Update in Palliative Care • Mary Lynn McPherson, PharmD,
BCPS
Clinical Session:
IDSA Treatment Guidelines for Candidiasis, Invasive Aspergillosis,
and Use of Antimicrobial Agents in Neutropenic Patients with Cancer
• Melissa D. Johnson, PharmD, MHS
Technical Session:
Facing the Challenges: Opening a New Clinic/Chemo Prep
Area • Michele A. Woods, PharmD, BCOP
BCOP Presentation:
Updates on Prostate Cancer • Barry R. Goldspiel, PharmD,
BCOP
Clinical Session:
Clinical Pharmacogenetics • Jill M. Kolesar, PharmD,
BCPS, FCCP
Technical Session:
Do “Closed Systems” Make Handling of Chemotherapy Safer?
• Yaakov Cass, MSc, FRPharmS
Symposium:
Diagnosis and Therapy in Chronic Lymphocytic Leukemia
(Supported by an educational grant from Cephalon Oncology)
• Treatment Strategies in B-Chronic Lymphocytic Leukemia • Amy
Hatfield Seung, PharmD, BCOP
• Reimbursement Issues: Choices Based on Cost • Niesha L. Griffith, MS,
RPh
Symposium:
Targeted Drug Therapies for the Treatment of Non–Small-Cell
Lung Cancer
(Supported by an educational grant from Bristol-Myers Squibb Company)
• Targeted Therapies: Place in Therapy for NSCLC • Sara K. Maier,
PharmD, BCPS, BCOP
• Future Developments in NSCLC: Use of Targeted Therapy • Val R. Adams,
PharmD, FCCP, BCOP
Platform Awards:
• P1. Interaction Between Methotrexate and Omeprazole in an Adolescent
with Leukemia: a Case-Report • Tiene G. M. Bauters
• P2. Evaluation of the Modification of Diet in Renal Disease and Cockcroft-Gault
Formulas in the Calvert Equation for Carboplatin Dosing • LeAnn B. Norris,
PharmD
• P3. Rapid Infusion of Trastuzumab 6 mg/kg Is Safe and Improves Efficiency
• Michael Moloney, BPharm, Grad Dip Clin Pharm
• P4. Development and Implementation of an Off-Label Medication Use Policy
at a Comprehensive Cancer Center • Niesha L. Griffith, MS, RPh
Significant Papers in Hematology/Oncology:
View combined presentation
- Vitamin D in Cancer Prevention • Mário de Lemos, BSc (Pharm),
MSc (Clin Pharm), PharmD, MSc (Oncol), MRPharmS
- Clinical Advances in Brain Tumors • Cyrine E. Haidar, PharmD, BCPS,
BCOP
- Acute Promyelocytic Leukemia • Laura E. Wiggins, PharmD, BCOP
Symposium:
Updates in Cancer Supportive Care: Venous Thromboembolism,
Tumor Lysis Syndrome, and Chemotherapy-Induced Nausea and Vomiting
(Supported by educational grants from MGI PHARMA and Sanofi-Aventis)
• Current Practice in the Prevention and Treatment of Venous
Thromboembolism • Chad M. Barnett, PharmD, BCOP
• Evolving Directions for Tumor Lysis Syndrome Prevention and Treatment
• Ashley Morris Engemann, PharmD, BCOP
• What’s New in CINV Prevention and Management • Sally Y. Barbour, PharmD,
BCOP, CPP
Day 3: Friday, June 20, 2008
Symposium:
Clinical and Pharmacoeconomic Implications of Iron Supplementation
in Cancer Patients with Anemia
(Supported by an educational grant from Watson)
• Why IV Iron in Cancer Patients With Anemia? • Stacy S. Shord,
PharmD, BCOP
• Clinical and Pharmacoeconomic Benefits of IV Iron • David M. Baribeault,
RPh, BCOP
BCOP Presentation:
Chronic Myeloid Leukemia: 2008 Update • Christopher
A. Fausel, PharmD, BCPS, BCOP
Clinical Session:
Updates on Soft Tissue Sarcoma • Alexandre Chan, PharmD,
BCPS, BCOP
Technical Session:
Pharmacy Technician Certification Programs • Lita
Chew
BCOP Presentation:
The Changing Endpoints and Outcomes in the Oncology Drug
Approval Process • Scott A. Soefje, PharmD, BCOP
Clinical Session:
Erythropoiesis Stimulating Agents Update • David M.
Baribeault, RPh, BCOP & Cindy L. O’Bryant, PharmD, BCOP
Technical Session:
Update on NIOSH Activities and USP <797> • Thomas
H. Connor, PhD
BCOP Presentation:
Head and Neck Cancers Update • Sarah L. Scarpace, PharmD,
BCOP
Clinical Session:
Hematopoietic Cell Transplant • Jeannine S. McCune,
PharmD
Technical Session:
ISOPP Safe Handling Standard • Johan Vandenbroucke,
PharmD
Symposium:
What’s New in the Management of Multiple Myeloma
(Supported by an educational grant from Celgene)
• Current Strategies to Improve Outcomes in Myeloma • Brian G.M.
Durie, MD
• Practical Strategies for the Application of Novel Agents for the Frontline
Treatment of Multiple Myeloma • Casey B. Williams, PharmD, BCOP
Workshops:
1. Sickle Cell Disease • Tracy M. Hagemann, PharmD &
James Tjon, BSPharm, PharmD
2. Patients’ Information and Support Needs • Klaus Meier
3. Current Concepts in the Management of HIV-Related Malignancies
• Marjorie Adams Curry, PharmD
4. Medication Errors • Sylvia B. Bartel, RPh & Lita
Chew, MMedSc, BCPS, BCOP
5. Extravasation Update • Robert McLauchlan, BSc (Hons)
Pharm, Grad Dip Hosp Pharm, BCOP
6. Supportive Care • Joseph S. Bubalo, PharmD, BCOP, BCPS
& Alexandre Chan, PharmD, BCPS, BCOP
7. Unique Opportunities for Pharmacists (Research, Guidelines,
Legislative) • Cindy L. O’Bryant, PharmD, BCOP; Sally Y. Barbour, PharmD,
BCOP, CPP; and Timothy Tyler, PharmD, FCSHP
Symposium:
Individualized Colorectal Cancer Therapy: State of the
Art in 2008
(Supported by an educational grant from Genentech)
• Understanding the Standard of Care for Colorectal Cancer •
Andrea N. Landgraf, PharmD, BCOP
• Emerging Treatment Strategies for Colon Cancer • Patrick Medina, PharmD,
BCOP
Day 4: Saturday, June 21, 2008
Symposium:
Integrating the Epothilones into Clinical Practice: Focus
on Breast Cancer
(Supported by an educational grant from Bristol-Myers Squibb Company)
• Epothilones: Pre-clinical Data and Early Clinical Efficacy
in Breast Cancer • Susan Goodin, PharmD, FCCP, BCOP
• Epothilones: Integrating Therapy into Clinical Practice • Laura Boehnke
Michaud, PharmD, BCOP, FASHP
General Session:
Update on Emerging Investigational Agents • John G.
Kuhn, PharmD, FCCP, BCOP
Workshops:
8. ASCO Update • Christopher A. Fausel, PharmD, BCPS, BCOP
& Jolynn K. Sessions, PharmD, BCOP
9. Drug Interactions in Oncology • Suphat Subongkot, PharmD,
BCPS, BCOP
10. Safety in the Workplace • Sylvie Crauste-Manciet, PharmD,
PhD
11. Now For the Encore - Following Up Transplant Survivors
• Julie Wilkes, B Pharm, P Grad Dip Pharm, BCOP
12. A Pharmacist’s Guide to Practical Cancer Pain Management
• Kimberley Stefaniuk, BSP, RPEBC
13. Therapeutic Challenges in Pediatric Cancer • John N.
McCormick, PharmD, BCNSP
14. Chemotherapy Dosing in Special Populations • Sabine Kaestner,
MSPharm, PhD
Symposium:
Epigenetic Therapy: From Bench-to-Bedside
(Supported by an educational grant from Celgene)
• Epigenetics in Cancer Medicine • R. Donald Harvey, PharmD,
BCPS, BCOP
• Hematologic Applications of Epigenetic Therapies • Laura E. Wiggins,
PharmD, BCOP
